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Abstract
Background: C. difficle spores in the environment of patients with C. difficile associated disease (CDAD) are difficult
to eliminate. Bleach (5000 ppm) has been advocated as an effective disinfectant for the environmental surfaces of
patients with CDAD. Few alternatives to bleach for non-outbreak conditions have been evaluated in controlled
healthcare studies.
Methods: This study was a prospective clinical comparison during non-outbreak conditions of the efficacy of an
accelerated hydrogen peroxide cleaner (0.5% AHP) to the currently used stabilized hydrogen peroxide cleaner
(0.05% SHP at manufacturer recommended use-dilution) with respect to spore removal from toilets in a tertiary
care facility. The toilets used by patients who had diarrhea with and without C. difficile associated disease (CDAD)
were cultured for C. difficile and were monitored using an ultraviolet mark (UVM) to assess cleaning compliance on
a daily basis 5 days per week. A total of 243 patients and 714 samples were analysed. The culture results were
included in the analysis only if the UVM audit from the same day confirmed that the toilet had been cleaned.
Results: Our data demonstrated that the efficacy of spore killing is formulation specific and cannot be generalized.
The OxivirTB® AHP formulation resulted in statistically significantly (p = 0.0023) lower levels of toxigenic C. difficile
spores in toilets of patients with CDAD compared to the SHP formulation that was routinely being used (28% vs
45% culture positive). The background level of toxigenic C. difficile spores was 10% in toilets of patients with
diarrhea not due to CDAD. The UVM audit indicated that despite the enhanced twice-daily cleaning protocol for
CDAD patients cleaning was not achieved on approximately 30 - 40% of the days tested.
Conclusion: Our data indicate that the AHP formulation evaluated that has some sporicidal activity was
significantly better than the currently used SHP formulation. This AHP formulation provides a one-step process that
significantly lowers the C. difficile spore level in toilets during non-outbreak conditions without the workplace safety
concerns associated with 5000 ppm bleach.
Background
Toxigenic Clostridium difficile causes a significant num-
ber of enteric infections world-wide [1-5]. In Manitoba,
where C. difficile associated diarrhea (CDAD) is reporta-
ble, there were 985 cases of CDAD compared to 512
cases of all other enteric bacterial infections combined
in 2007 [6]. The incidence of CDAD ranges from 3.4
cases/1000 admissions up to 50 cases/1000 admissions
[1,7]. The rates of CDAD per 100,000 population in the
USA have almost doubled between 1996 and 2003 [8].
A major reservoir linked to nosocomial infections is
thought to be the environment of healthcare facilities
that are contaminated with the C. difficile spores shed by
patients with CDAD [1,7,9,8,10,11]. The persistence of
C. difficile spores has been well documented with toilets
having the highest levels [1,9,12]. Reducing C. difficile
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surface disinfectant and/or cleaning agents have sporoci-
dal activity in a short enough time-frame (e.g. 3 minutes)
to be effective [13].
National guidelines in Canada do not recommend disin-
fectants for routine housekeeping [14] but many health-
care facilities use bleach at a 1:10 dilution (5,000 ppm) and
increase cleaning from once to twice daily for patients
with CDAD as per PIDAC[9,10,12,15]. Despite being
widely accepted, neither Wilcox’s original study [16]
nor Eckstein’s recent study [9] were able to demonstrate
complete eradication of spores when 5,000 ppm bleach
was used for cleaning/disinfecting toilet facilities of
patients with CDAD. In most published studies, bleach at
5,000 ppm was combined with other heightened strategies
such as improved housekeeping, enhanced compliance
with infection control isolation precautions, and increased
education [10]. Although 5,000 ppm chlorine bleach is an
effective sporicidal agent, there are significant workplace
safety concerns related to using bleach and it requires a
two step process (i.e. must be wiped off using water).
There are no published studies that have audited cleaning
compliance in conjunction with evaluating bleach alterna-
tives (that have some sporicidal activity) that could be
used for environmental cleaning of CDAD patient toilets
during non-outbreak conditions.
The objective of this research was to determine if the
presence of C. difficile spores in toilets of patients with
CDAD could be reduced in non-outbreak conditions
when a non-bleach based disinfecting agent that had
some sporicidal activity was used for cleaning toilets. To
ensure that the intervention was used the toilets were
audited with UVM and only if the toilet had received
cleaning was the culture date included in the overall
analysis.
Methods
1. Microorganisms used in this study
C. difficile strain 726 was a clinical isolate that was used
for spore preparation as described by Alfa et al [17].
The spore preparation of ~10
6 spores/mL was stored in
45% alcohol and the same batch of spores was used for
all testing.
2. Preliminary testing to select the intervention
formulation
The efficacy of various disinfectant solutions at killing
spores of C. difficile was assessed using suspension and
surface testing. The use of ATS (artificial test soil) as an
organic challenge and the recovery of residual C. difficile
spores from inoculated toilet seats by Rodac plates is
described by Alfa et al [17]. Five different chemical dis-
infectants were evaluated; PerDiem at 1:16 use-dilution
(research based use-dilution that is not recommended
by the manufacturer), OxivirTB® used directly (manufac-
turer’s recommended use-dilution), Bleach at 500, 1000
and 5000 ppm. C. difficile spores (in ATS as an organic
challenge) were used to inoculate the surface of a toilet
seat (4 Log10 spores per site) and dried overnight. Each
disinfectant was sprayed to completely wet the inocu-
lated surface and allowed to remain in contact with the
surface until completely dried (~10 minutes) with no
surface wiping or allowed to remain in contact with the
surface for 3 minutes followed by a manual wipe using
sterile gauze that was pre-moistened with the same dis-
infectant. The level of residual viable spores was then
assessed using the Rodac plate technique. Each experi-
ment was performed in triplicate and each count was
performed in triplicate. Results represent the mean ±
standard deviation of all 9 counts. Toilet seats were
inoculated with an organic challenge and spores as
described in methods.
3. Detection of C. difficile spores in toilets (clinical use
testing)
Each day the patient’s toilet was assessed using Rodac
plates containing CDMN agar (samples surface area of
25 cm
2) for detection of the presence of C. difficile spores
as described previously [18]. The same Rodac plate was
used to sequentially sample four areas of the toilet (under-
side of the toilet lid, toilet seat surface and underside, as
well as the inside rim of the upper portion of the toilet
bowl) for a total surface are of 100 cm
2. The identification
of isolates and the confirmation of toxin production was
as previously described by Alfa et al [18].
4. Disinfectant cleaners evaluated
OxivirTB® is an accelerated hydrogen peroxide (AHP)
formulation that is marketed for use in healthcare,
medical, industrial and institutional facilities. It has an
M. tuberculosis label claim and is sold in a ready to
use format that contains 0.5% AHP. The manufacturer
recommended contact time is 1 minute. PerDiem is a
stabilized hydrogen perox i d e( S H P )t h a ti su s e df o r
routine housekeeping at 1:64 dilution (0.0469 final
concentration of SHP at use-dilution of 1:64). There
i sn on e e df o rs p e c i a lP P Ef o re i t h e rP e r D i e mo r
OxivirTB® at the use-dilutions and no wipe-off of resi-
dual disinfectant is needed. The manufacturer recom-
mended contact time is 10 minutes for PerDiem.
PerCept is a Hydrogen peroxide (HP) formulation that
contains 7% HP that is to be diluted at 1:16, carries a
broader spectrum of efficacy than PerDiem with a
5-minute contact time and is intended for disinfection
of environmental surfaces and non-critical devices. In
concentrate at 7%, this formulation has special PPE
requirements; however, at the use dilution does not
require special PPE. Bleach (5% household bleach
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use-dilutions of 5,000 ppm, 1,000 ppm and 500 ppm
(prepared fresh daily). Bleach does require special PPE
at 5,000 ppm and also requires a wipe-off after appro-
priate contact time (no minimum manufacturer recom-
mended contact time for household bleach).
5. Cleaning Compliance assessment tool
Glitterbug lotion (Brevis Inc) was used as the UV-visible
marker (UVM) on the undersides of the toilet seat as an
audit to ensure housekeeping staff had cleaned the toi-
let. The value of UVM as an audit tool of cleaning com-
pliance has been described by Alfa et al [18]. If this
marker was not removed it indicated that the toilet had
not been cleaned as per the protocol therefore the cul-
ture results from the Rodac Plates taken on that day
would not reflect the efficacy of the agent tested because
it was not applied to the toilet. Only if the UVM was
removed was the Rodac culture result included in the
final data analysis.
6. Housekeeping protocol for cleaning toilets; routine and
enhanced
PerDiem at a 1:64 use-dilution was used for routine
cleaning of patient toilets. The toilet cleaning instruc-
tions required that all surfaces (including the underside
of the toilet lid and seat) be sprayed to entirely wet the
toilet surfaces. The solution was to be in contact with
the toilet surface while the housekeeper finished clean-
ing the other areas of the bathroom (observational stu-
dies indicated that this required from 3 - 5 minutes).
The toilet was then to be wiped using a cloth wetted
with the same use-dilution PerDiem solution. The toilet
was cleaned last and the cleaning cloth was not to be
used for any other cleaning - it was sent for laundering.
The toilet was to be cleaned once per day. The
enhanced housekeeping protocol (twice daily cleaning)
used by this hospital was for toilets of patients who
were on isolation precautions due to CDAD. PerDiem at
the standard 1:64 use-dilution was used for the
enhanced protocol. The cloths used for all cleaning
were cotton material of varying thickness made from
old bedsheets.
7. Study protocol
Patients with diarrhoea were enrolled in 3 Arms as
s h o w ni nF i g u r e1 .N os a m p l e sw e r et a k e nf r o mt h e
patients and only the patient’s toilet was evaluated. The
Research and Ethics committee approved that informed
consent of patients who used the toilet evaluated was
not needed. The hospital site where this study was
undertaken was a 450 bed acute care facility. All house-
keeping staff were informed that a study was being done
that included a UVM audit, however, they were not
notified which wards or patient rooms would be
assessed. It was made clear to the housekeepers that no
punitive action would result from the audits performed
during this study. The healthcare facility had dedicated
housekeepers for each ward. Staff were instructed and
signs were placed in the toilets clearly indicating that
the bottles of cleaner were not be removed or changed
and that only these specific bottles were to be used for
the cleaning. Each day the research staff checked the
rooms to ensure the proper agent was being used. The
diagnostic test results for all stool samples submitted to
the diagnostic lab for C. difficile toxin testing were
reviewed on a daily basis and the toilet of each patient
enrolled was prospectively evaluated for 5 days of sam-
pling unless patient died or was discharged before the
five samples were collected.
Data analysis
Data was entered into an excel spreadsheet and some
statistical analysis determined using GraphPad Instat
Program.
Results
The objective was to select a cleaning agent that had
microbial killing ability that did not require an additional
rinse step after application and had some C. difficile spor-
icidal activity within a short period of time. The selected
formulation would then be used for a prospective clinical
study. Preliminary in vitro testing (Figure 2) of various
disinfectant formulations using simulated-use suspension
testing in the absence of an organic challenge indicated
that the OxivirTB® formulation provided a 2-3 Log10 kill
of C. difficile spores after only 1 minute exposure. The
suspension killing for OxivirTB® was not as efficient as
that achieved for bleach 5000 ppm but was equivalent to
bleach 1000 ppm after 1 min. The other HP formulations
tested did not have efficient spore killing ability within
1 - 5 mins. Further testing of the efficacy of C. difficile
spore killing on surfaces in the presence of an organic
c h a l l e n g ew e r ea l s op r e f o r m e d( F i g u r e3 ) .I fas p r a ya n d
wipe cleaning process was used 5000 ppm bleach was the
most effective, whereas if no wiping was performed then
OxivirTB® and 5000 ppm bleach were not statistically
different in their spore killing ability. Since the objective
was to identify an alternative to 5000 ppm bleach, the
OxivirTB® formulation was selected for the intervention
study as it had rapid (but not complete) sporicidal activ-
ity yet does not require special PPE and does not need
the additional step of being wiped off with water (i.e. is a
one step process).
The efficiency of detection of C. difficile spores on
surfaces by Rodac plates containing CDMN agar was
assessed using a known concentration of spores inocu-
lated and dried onto plastic, tin-foil and toilet seat sur-
faces (Table 1).
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ken between December 2005 and July 2007. Patients in
Arms 1, and 2 were prospectively followed while on iso-
lation precautions for at least 1 week post diagnosis of
CDAD unless discharged earlier or taken off of isolation
precautions. Patients in Arm 3 (not on isolation) were
prospectively followed for at least 1 week unless dis-
charged earlier. Although patients who are treated for
CDAD are known to shed spores for prolonged periods,
the expectation was that the time of highest likelihood
of having C. difficile spores shed into the toilet was dur-
ing the first week post-diagnosis.
To ensure the cleaning agents (both AHP and SHP)
were applied to the toilets, a UV visible marker (UVM)
was used on the underside of the toilet seat following
t h ep r o t o c o lo fA l f ae ta l[ 1 8 ] .O u rd a t a( F i g u r e4 )
showed 30 to 41% of the toilets had a UVM score of 3
indicating the marker was not removed, therefore, not
cleaned according to the housekeeping protocol. The
overall average UVM scores were 1.48, 1.40, 1.48 and
1.63 for Arms 1, 2, and 3 respectively (not significantly
different by ANOVA, p = 0.4253). To ensure reliable
conclusions, the data on C. difficile culture results was
stratified based on UVM audits. Figure 5 summarizes
Figure 1 Overview of Patient Enrolment. All patients were followed prospectively and samples collected for five days unless the patient was
discharged or died. OxivirTB® has 0.5% AHP at its use-dilution, and PerDiem at a 1:64 use-dilution has 0.05% SHP.
Figure 2 Efficiency of chemical disinfectants on C. difficile spores in suspension. The ability of OxivTB (0.5% AHP), PerCept (7% AHP),
PerDiem 1:64 (0.05% SHP), PerDiem 1:16 (0.5% SHP), 500 ppm NaOCl, 1000 ppm NaOCl and 5,000 ppm NaOCl to kill C. difficile spores was
assessed at increasing exposure times was assessed. There was no organic challenge used for this analysis. All tests were performed in triplicate
and reported as the mean ± standard deviation.
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samples collected from toilets where the UVM con-
firmed there had been some level of cleaning (i.e. UVM
<3) versus when the UVM was 3 (no cleaning). Arm 1
(intervention agent) had significantly lower spore levels
compared to Arm 2 (currently used protocol).
Discussion
Our study is the first to incorporate UVM as an audit to
confirm that cleaning of the toilet was done during the
assessment of an alternative cleaning formulation. Our
data indicated that the compliance with the housekeep-
ing cleaning policy (i.e. UVM score <3) was about 60%
Figure 3 C. difficile spore removal from surfaces using spray only versus spray and wipe cleaning processes. The data presented in A)
represents “spray” only with no wiping of the surface prior to sampling with Rodac plates, whereas the data presented in B) represents a
combination of “spraying” followed by “wiping” (single pass of the cloth) after 3 minutes of contact time. Those bars indicated by “*” represent
all three samples where the number of colonies on the Rodac plate was too high to count, therefore, the samples were assumed to have
≥4log10 cfu/site for graphing purposes.
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reported in regular as well as ICU rooms [19-21].
Despite the policy requiring cleaning of toilets twice per
day for patients with CDAD, this was not being
achieved 40% of the time. Recently a number of pub-
lished reports [18,22-24] have indicated that the cur-
rently accepted benchmark of “visibly clean” is an
inadequate audit approach in healthcare facilities. Alter-
native audit tools suggested include ATP biolumines-
cence and culture [22,23] with cleaning considered
inadequate at ATP levels ≥ 500 RLU/cm
2 or when cul-
ture showed >1 cfu/cm
2 of C. difficile. Although using
ATP based audit tools [22-24], or culture may provide a
more direct measure of the residual bioburden, the
UVM method provides an inexpensive and easy method
for sites to accurately audit cleaning compliance (i.e.
physical wiping of the surface) and this assessment is
critical when comparing a possible alternative disinfect-
ing/cleaning agent to a current agent.
Although Rodac plates containing CDMN provide
excellent recovery of C. difficile spores from toilet sur-
faces (86%), it should be noted that C. difficile spores in
a patient-used toilet will notb ee v e n l yd i s t r i b u t e da n d
our Rodac sampling method (sampled 100 cm
2)r e p r e -
sented only about 10% of the total toilet surface area
that could be contaminated. Dispite this caveat the
Rodac sampling method provides a good indication of
the level of spore contamination as it samples the sites
most likely to be contaminated after patient-use or after
the contents of a bedpan are disposed of in the toilet.
The daily monitoring of C. difficile spores in the
patient toilet using Rodac plates provided direct assess-
ment of the impact of the cleaning agent on spore
removal/killing. Physical cleaning is not sufficient alone
to eliminate spores and use of a disinfectant may be
needed to provide an efficient means of reducing the
level of environmental spores. Although chlorine releas-
ing agents are optimal for spore killing even 5,000 ppm
bleach has been reported as not totally effective
[1,7,9,23]. The previous published clinical studies did
not have audits to ensure cleaning compliance, as such
the suboptimal results obtained using 5,000 ppm bleach
(up to ~20% still having C. difficile) may be due to lack
of housekeeping compliance. However, [9] Eckstein
Table 1 Efficacy of Rodac plates for recovering C. difficile
spores dried onto surfaces
Recovery Log10 cfu/site
(± std)*
% recovery
(+ std)
1. Plastic Petri
dish
2.041 (0.125) 80.81 (4.96)
2. Tin foil 2.186 (0.015) 86.6 (0.61)
3. Toilet seat 2.162 (0.008) 85.7 (3.03)
* The surface area inoculated was equivalent to the surface area sampled
when using the Rodac plate. All experiments were performed in triplicate. The
average inoculum per surface area inoculated (i.e per site) was Log10 2.524 ±
0.009 cfu/site. A range of surface inoculation levels were evaluated, but higher
inoculum (e.g. ≥ 10
3 cfu/site) of C. difficile spores produced growth that was
too numerous to count when sampled using Rodac plates.
Figure 4 Overall UVM audit to assess the cleaning efficacy in each arm of the study. The data represents the overall average percent of
samples in each Arm showing 0, 1, 2 or 3 as the UVM cleaning score. This is based on data from the first 5 days of samples for each patient in
each Arm. This represents 133 samples from 50 patients in Arm 1 (solid bars), 254 samples from 68 patients in Arm 2 (white bars) and 179
samples from 68 patients in Arm 3 (hatched bars).
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cleaning that 5000 ppm bleach was not totally effective
at eradicating C. difficile spores from patient toilets
(10% still having C. difficile). Our data indicated that
although bleach at 500 to 5,000 ppm was effective at
killing C. difficile spores in suspension in 5 minutes, it
was not as effective when surface testing in the presence
of an organic challenge was used. Perez et al [13] have
shown that 5,000 ppm bleach needs 5 - 8 mins to pro-
vide a 6 Log10 reduction in C. difficile spores. OxivirTB®
was as effective as 5000 ppm bleach when tested on sur-
faces with an organic challenge without physical wiping
(neither was completely effective without wiping). Perez
et al’s [13] data also support the value of AHP for C.
difficile spore killing. However, the formulation they
tested is designed for medical device reprocessing and
therefore requires special PPE as well as a second wipe
with water to remove the AHP residuals. Neither the
AHP formulation (OxivirTB) or the SHP formulation
(PerDiem) used for the current study require special
PPE or a second wipe to remove residuals. There have
been published reports that the use of AHP disinfecting
cleaners have been associated with outbreak control and
reduced rates of CDAD [11].
Our study is the first to provide data that a one stage
cleaning process using an AHP (0.5%) formulation can
significantly reduce the load of C. difficile spores in the
toilets of patients with CDAD during non-outbreak con-
ditions. Our study demonstrated that the AHP interven-
tion resulted in toilet spore levels (27.8%) nearly
equivalent to those found when Eckstein et al [9] used
5,000 ppm bleach (~20%). It is critical that for “inter-
vention studies” that cleaning compliance is audited. If
the toilet has not been cleaned, results should not be
included in the analysis of the intervention as the con-
clusions may be misleading.
Panessa [25] et al have reported that despite not being
metabolically active, spores do attach to surfaces espe-
cially when sporulation is initiated. This ability of spores
to attach combined with lack of cleaning compliance by
housekeeping staff may be the basis for accumulation of
spores and high positivity rates in toilets and high-touch
areas of the rooms of patients with CDAD [1,7,9,11,26].
Despite a housekeeping policy requiring enhanced fre-
quency of cleaning (twice per day) for CDAD patient
isolation rooms, C. difficile spores were still detected in
approximately 50% of toilets. Although this may be
partly due to the housekeeping protocol not stipulating
10 minutes contact time with the use-dilution of
PerDiem (as per manufacturer’s contact time recom-
mendations) it is unlikely that re-wetting the surface to
provide 10 minutes contact time would have improved
elimination of C. difficile spores as our preliminary test-
ing showed that this formulation had essentially no
Figure 5 Effect of cleaning protocol on C. difficile detection in toilets. Data for toilets where UVM was 3 (no cleaning) was compared to
toilets that received some cleaning (UVM of 0, 1, 2). See Materials and Methods and Figure 1 for differences in patient population and cleaning
protocols used for Arms 1 to 3. Arm 1 had 50 patients enrolled and a total of 133 samples (79 samples with UVM <3 and 50 samples with UVM
= 3), Arm 2 had 68 patients and 254 samples (153 samples with UVM <3 and 101 samples with UVM = 3) and Arm 3 had 68 patients enrolled
with 179 samples (100 samples with UVM <3 and 79 with UVM = 3. Arm 1 showed significantly lower detection of toxigenic C. difficile detected
compared to Arm 2* (p = 0.0023, CI of 0.4589 to 0.8482). The white bars represent results for samples with a UVM <3 (some cleaning) and the
solid bars represent results from samples with a UVM = 3 (no cleaning).
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exposure in suspension testing. The lack of ability of
PerDiem (routinely used throughout the hospital) to
eliminate spores may also explain why the background
level of C. difficile is 10% even in rooms of patients
without CDAD. Alternatively, this may be the lowest
environmental level of C. difficile spores that can be
achieved in healthcare facilities as our background level
of 10% was similar to the residual level of spores when
research staff did toilet cleaning in patient rooms using
5,000 ppm bleach [9]. The efficacy of any cleaning/disin-
fecting agent tested is dependent on physical action. We
recommend that healthcare facilities need to ensure that
adequate time is allowed for cleaning of patient rooms
and that adequate audits are used to ensure compliance
with the cleaning protocol.
Conclusion
In conclusion, our data demonstrated that the use of an
agent with some sporicidal activity for cleaning resulted
in significantly reduced C. difficle spore levels in toilets
of patients with CDAD during non-outbreak conditions.
Infection transmission within healthcare will remain
problematic if the role of housekeeping remains under-
valued and if they are not provided with adequate audit
tools such as UVM to ensure sustained cleaning
compliance.
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